Agree Realty Corporation (ADC)

$12,300 a Month in Dividends and Not One Bond: Is This Portfolio Too Good to Be True?

Why Investors Need to Take Advantage of These 2 Finance Stocks Now

How to Turn $100,000 Into Steady Monthly Income for Retirement

Why High-Yield REITs and BDCs Can Be Powerful Income Stocks Inside a Roth IRA

Why Investors Need to Take Advantage of These 2 Finance Stocks Now

5 Monthly Dividend Stocks That Could Turn Your Portfolio Into a Second Paycheck

ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements

Realty Income or Agree Realty: If I Could Only Collect One Monthly Dividend Until Retirement, It Would Be This One

Better Dividend Stock for 2026: NNN or ADC? One Clearly Wins on Yield and Growth

3 Monthly Dividend Payers That Could Replace an October Paycheck

AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics

TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) Technology

Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

How to Build $12,100 a Month in Dividend Income From Three Income Buckets

Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer

How Much Do You Need Invested to Double the Average Social Security Check With Dividends?

2 A-Rated REITs Getting Too Cheap Amid Rising Bond Yields

Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway

Rates Are Hammering REITs. These 5 Dividends Are Built to Hold Up

Defence Therapeutics to Take the Stage at World ADC San Diego to Discuss the Next Frontier in Antibody-Drug Conjugates